Equities

Somnomed Ltd

Somnomed Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.265
  • Today's Change0.005 / 1.92%
  • Shares traded5.00k
  • 1 Year change-60.43%
  • Beta1.5642
Data delayed at least 20 minutes, as of May 31 2024 02:51 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Company’s segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.

  • Revenue in AUD (TTM)88.78m
  • Net income in AUD-10.51m
  • Incorporated1987
  • Employees300.00
  • Location
    Somnomed LtdLevel 3, 20 Clarke St, Crows NestSYDNEY 2065AustraliaAUS
  • Phone+61 29467-0400
  • Fax+61 29467-0467
  • Websitehttps://somnomed.com/en/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wellnex Life Ltd20.31m-19.39m32.24m----4.16--1.59-0.0347-0.03470.03590.0060.7122.974.64---67.96-79.54-133.68-99.2812.7710.10-95.45-235.500.2654-5.240.5516--49.8177.66-85.88------
Universal Biosensors, Inc.6.81m-6.39m41.73m97.00--1.84--6.13-0.0304-0.03040.03150.07620.19410.60253.61---18.23-21.79-24.51-27.1462.9746.16-93.90-209.313.02--0.0342--46.58-37.4874.90--26.83--
Curvebeam AI Ltd8.78m-57.55m42.62m50.00--1.32--4.86-0.18-0.180.02750.14770.13470.56183.47---88.33---115.31--48.78---655.67--1.97-3.100.2364--381.77---509.11------
Nova Eye Medical Ltd18.70m-14.31m51.49m130.00--2.59--2.75-0.0797-0.07970.1020.0870.68050.48228.34---52.10-12.19-64.18-14.9390.2082.04-76.56-60.210.8106--0.0666--27.71-26.42-104.02---28.45--
Compumedics Limited49.62m1.23m53.15m135.0042.132.9520.751.070.00710.00710.31070.10181.242.144.43367,540.803.07-2.916.53-4.6353.5453.442.48-2.900.74832.010.3385--12.322.76-551.14--16.84--
Micro-X Ltd15.17m-14.51m54.04m----4.84--3.56-0.0281-0.02810.02940.01920.54250.85189.08---51.87-43.99-67.43-59.1463.5865.04-95.61-130.781.28-56.110.3033--14.4222.2537.07--23.88--
Somnomed Ltd88.78m-10.51m57.27m300.00--1.24--0.6451-0.0917-0.09260.78220.21311.387.767.52---16.35-5.23-22.50-7.8461.7660.17-11.84-4.131.45-2.030.3827--15.215.56-77.73--24.17--
Orthocell Ltd6.06m-7.42m77.45m----33.85--12.79-0.0369-0.03690.03010.01090.21821.5027.68---26.73-32.67-31.96-38.5377.1163.04-122.55-374.464.36--0.2586--215.2451.5331.39--11.07--
Data as of May 31 2024. Currency figures normalised to Somnomed Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

44.94%Per cent of shares held by top holders
HolderShares% Held
TDMAM Pty Ltd.as of 25 Sep 202342.09m19.48%
Australian Ethical Investments Ltd. (Investment Management)as of 08 May 202434.24m15.85%
FIL Investment Management (Hong Kong) Ltd.as of 30 Apr 202414.14m6.54%
Fidelity Management & Research Co. LLCas of 22 Dec 20235.72m2.65%
FIAM LLCas of 22 Dec 2023497.68k0.23%
QS Investors LLCas of 31 Mar 2024433.97k0.20%
More ▼
Data from 25 Sep 2023 - 27 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.